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MARTINA RUEFFER, WOLFGANG BAUER, and MEINHART Η. ZENK. Can. J. Chem. 7 2 , 170 (1994). 
The biosynthesis of corydaline and thalictricavine has been investigated by application of [8-3H]-labelled palmatine and ber-
berine to Corydalis cava bulb tissue. In both cases, high incorporation into the respective (14/?,135)corydaline and 
-thalictricavine was observed. (5)-[ 14- 3H, 8- l4C)Scoulerine was also transferred into corydaline with all of the tritium being lost, 
indicating that a redox reaction had taken place in the transition of the (145) to the (14/?) product. A partly enriched protein frac­
tion catalyzed the reduction of both protoberberine precursors to the 7,8-dihydro intermediate, which was subsequently methy­
lated at C-13 at the expense of 5-adenosylmethionine (SAM) and reduced at C-14 by a B-type reaction with NADPH as 
reductant. The identity of the product was unequivocally established by NMR, MS, and CD measurements. This biosynthetic 
route is in full agreement with previously published predictions based on in vivo experiments. 
MARTINA RUEFFER, WOLFGANG BAUER et MEINHART Η . ZENK. Can. J. Chem. 7 2 , 170 (1994). 
On a etudie la biosynthese de la corydaline et de la thalictricavine en appliquant de la palmatine et de la berberine marquees au 
[8- 3 H] ä des tissus bulbaires de Corydalis cava. Dans les deux cas, on a observe une incorporation elevee dans les 
(14/?,135)-corydaline et -thalictricavine respectives. La (5)-[14- 3H, 8- ,4C]scoulerine se transforme aussi en corydaline avec une 
perte des trois atomes de tritium; ceci indique qu'il se produit une reaction redox lors de la transformation du produit (145) en 
produit (14/?). Une fraction partiellement enrichie en proteines catalyse la reduction des deux precurseurs protoberberines en un 
intermediate 7,8-dihydrog£ne qui est ulterieurement methyle en C-13 aux depens de la 5-adenosylm6thionine (SAM) et reduit 
en C-14 par une reaction de type Β ä Γ aide NADPH qui agit comme reducteur. On a determine sans ambiguity Tidentite du pro­
duit en faisant appel ä des mesures de RMN, de SM et de DC. Cette voie de biosynthese est en parfait accord avec les predictions 
publiees anterieurement et qui £taient basees sur des experiences in vivo. 
[Traduit par la redaction) 
The biosynthesis of select alkaloids of the protoberberine 
type has been clarified at the enzyme level using plant cell cul-
tures both from the Berberidaceae and the Ranunculaceae (1 -
3). These alkaloids, formed from two molecules of tyrosine, 
posed an interesting biosynthetic problem, in that tyrosine 
labelled both the isoquinoline "upper" and the benzyl "lower" 
portion of the benzylisoquinolines, while the more immediate, 
dihydroxylated precursors DOPA or dopamine unpredictably 
labelled only the "upper" half of these molecules (4). This ques-
tion was elegantly and expertly posed again more recently (5). 
This intriguing problem was solved when it could be demon-
strated that the trihydroxylated (S)-norcoclaurine but not the tet-
rahydroxylated (5)-norlaudanosoline is the precursor of the 
benzylisoquinoline alkaloids (6). (S)-Norcoclaurine is derived 
from the enzyme-catalyzed stereoselective condensation of 
dopamine with /7-hydroxyphenylacetaldehyde (1). The biosyn-
thetic pathway to berberine is now completely known also at the 
enzyme level (1-3). One of the remaining questions was, how-
ever, by which mechanism the (/?)-configurated tetrahydropro-
toberberine molecules are formed. It was found that a highly 
stereoselective and reversible enzyme system using N A D P H 
and protoberberine alkaloids as substrates reduced the C ring 
of protoberberines to yield the (7?)-configurated tetrahydropro-
toberberines (7). The hitherto claimed precursor role of 
(/?)-reticuline (8) in the biosynthesis of these alkaloids is incor-
rect. 
Corydalis cava is a rich source of benzylisoquinoline alka-
loids and variously modified molecules (9), among them 
(+)-corydaline (10, 11). The structure of this compound had 
been elucidated (12, 13) and the stereochemistry of both asym-
metric centers was solved (14). This alkaloid is of biosynthetic 
Author to whom correspondence may be addressed. Telephone 
(089) 59 02-244, Telefax (089) 59 02-611. 
(S)-Norcoclaurine: R = Η {/tVReticuline 
(S)-Coclaurine: R = CH3 
interest because it belongs to the (14/?) series of the tetrahydro-
protoberberines and, in addition, contains a rare one-carbon unit 
as methyl group at C-13. 
In an admirable set of experiments, MacLean, Spenser, and 
co-workers (5, 15) first found that corydaline was synthesized 
along the protoberberine route with its C-methyl group being 
supplied by methionine (15). Later, the important observation 
was made that palmatine and not (/?,5)-tetrahydropalmatine was 
the immediate precursor of corydaline (15). Some uncertainty, 
however, remained as to the true intermediates and precursors 
of this alkaloid. We now set out to clarify at the enzyme level the 
route by which this (/?)-configurated, C-methylated alkaloid is 
formed in the genus Corydalis. First, the incorporation experi­
ments reported by Holland et al. (5) were repeated but, instead 
of C. solida, differentiated plants of C. cava, which contain 
(147?,135)-thalictricavine (16) and (14/?,135)-tetrahydrocorys-
amine (17), in addition to (14/?,135)-corydaline (11), were 
used. Coptisine, palmatine, and berberine, all tritium-labelled in 
the 8-position, were separately supplied to bulbs of C. cava and, 
after being metabolized, the corresponding C-methylated end 
products were isolated. High relative incorporation rates of 24-
38% were observed (Table 1). These data confirm and extend 
the previous results obtained with a different plant species by 
Holland et al. (5). The above incorporation experiment was 
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Berberine : R 1 + R 2 = -CH2-; R 3 = CH3 ; R 4 = CH3 
Columbamine : R1 = CH3 ; R 2 = Η ; R 3 = C H 3 ; R
4 = CH3 Corydaline : R 1 = R 2 = R 3 = R 4 » C H 3 
Coptisine : R1 + R 2 = -CH2-; R 3 + R 4 = -CH2- Tetrahydrocorysamine : R1 + R 2 = -CH2-; R 3 + R 4 = -CH2-
Dehydroscoulerine : R1 = CH3 ; R 2 = Η ; R 3=H ; R 4 = CH3 Thalictricavine : R 1 + R 2 = -CH2- ; R 3 = CH3 ; R 4 = C H 3 
Jatrorrhizine : R 1 = Η ; R 2 = C H 3 ; R
3 = C H 3 ; R
4 = C H 3 
Palmatine : R 1 = R 2 = R 3 = R 4 = CH3 
T A B L E 1. Feeding of [8- Η]protoberberines to Corydalis cava bulb tissue 
Product Relative 
Total activity specific activity incorporation 
Substrate Product isolated (dpm) (dpm/μΓηοΙ) (%) 
Coptisine3 Tetrahydrocorysamine 9.60 χ 105 3.07 χ iO 6 32 
Palmatinea Corydaline 5.47 χ 105 5.0 χ 105 24 
Berberine8 Thalictricavine 9.65 χ 105 1.1 χ 105 38 
•Specific activity: 3.33 χ 104 Bq/μπιοΐ; a total of 1.85 χ 105 Bq was fed. 
7,8-Dihydroberberine 
repeated using a mixture of (S)-[14-3H]scoulerine and 
(S)-[8 1 4C]scoulerine, the 3 H / 1 4 C ratio being 9.8:1. (+)-Coryd-
aline was isolated from the tissue, diluted with unlabelled car­
rier corydaline, and recrystallized 6 times. Constant specific 
activity was attained already after the fourth recrystallization. A 
2.6% relative incorporation of (S)-scoulerine into corydaline 
was found and the initial 3 H / 1 4 C ratio of 9.8:1 was lowered to 
0.01:1. This indicated clearly that the tritium label was almost 
completely removed from position 14 of the (S)-scoulerine mol­
ecule and substantiated the previously found reversal of config­
uration from (5) to (R) by an oxido-reduction process as 
established for the formation of (/?)-tetrahydroprotoberberines 
from protoberberines (7). 
Since the C. cava tissue obviously has a high metabolic 
potential to convert protoberberines into the corydaline-type 
compounds, a cell-free system was tested to produce corydaline 
in vitro. A crude homogenate was prepared from C. cava bulbs, 
and was freed of contaminating low molecular weight com­
pounds by treatment with Sephadex G 25. Unlabelled palma­
tine was incubated with N A D P H and [ C 3 H 3 ] S A M in the 
presence of C. cava crude protein extract at pH 7.5. As shown in 
Fig. 1A, under these conditions a product was formed that had 
the same Rf value as authentic corydaline. Almost all radioac­
tive S A M had been converted to this product. In control exper­
iments either using heat-denatured enzyme (Fig. IB) or 
omitting N A D P H (Fig. 1C), no reaction occurred. In addition, 
the newly formed product had the same Rf value as corydaline 
in several other T L C solvent systems. To ascertain the identity 
of this product, the compound was diluted with unlabelled cory­
daline (calculated specific activity 1.5 x 10 4 αρητ/μιηο1), and 
recrystallized 6 times to yield a specific activity of 1.06 x 
10 4 dpm^mol . This experiment proved that corydaline was 
indeed formed under the conditions given in Fig. 1. Extension 
of this type of experiment showed that neither (R)- nor (S)-tetra-
hydropalmatine could serve as acceptor for the activated methyl 
group of S A M , and verified the in vivo experiments of Holland 
et al. (5) with regard to the precursorship of palmatine at the in 
vitro level. 
To obtain more insight into this rather complex reaction of 
reduction and C-methylation, we attempted to partially purify 
the corresponding enzyme. Since in preliminary experiments it 
was found that berberine was the best substrate, this substance 
was used for further experiments, (+)-thalictricavine being the 
end product of the reaction. The purification of the catalytic 
activity was carried out using 40 g of deep-frozen cells. Alka­
loids and other low molecular weight material were removed 
from the protein solution by passage through an X A D column. 
The eluate was loaded directly onto a DEAE-Sephacel column 
and the enzyme eluted with K C l . The pooled fractions were 
chromatographed on a hydroxy apatite column at pH 6.5. The 
enzyme did not bind to this column but was eluted with the 
washthrough. This protein solution was subjected to affinity 
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FIG. 1. Radioscan of an incubation mixture after TLC separation 
consisting of A: 25 nmol palmatine, l μπιοί NADPH, 27 pmol 
total 
with 
[C- }H 3]SAM (5 χ 10°dpm), 860 ug Corydalis cava protein, in a 
volume of 460 μι 50 mM KP<V" buffer, pH 7.5; B: as in A, but 
heat-denatured protein; C: as in A but without NADPH. 
chromatography employing an S A H - A H Sepharose 4B matrix. 
Elution of the enzyme was achieved with K C l . This procedure 
yielded a 54-fold purified enzyme with 32% yield based on the 
crude homogenate. The purification procedure is summarized 
in Table 2. The enzyme is a cytosolic protein; no evidence for its 
occurrence in an organelle could be found. The enriched 
enzyme showed a pH optimum at 8.0 and a temperature opti­
mum at 37°C (Figs. 2A and B). The M r of the enzyme was deter­
mined by gel permeation H P L C (using appropriate marker 
proteins) and showed a distribution coefficient that corresponds 
to a Mr of 56 000, assuming a globular shape of the protein. 
Lineweaver-Burk plots showed apparent KM values of 5 μ Μ 
for berberine, 16 μ Μ for N A D P H , and 2.7 μ Μ for S A M as sub­
strates. Using the same three substrates, a Kx value of 2.6 μ Μ 
was determined for S A H , which demonstrates that this 
homocysteine derivative, a reaction product, is a potent inhibi­
tor of the methyltransferase reaction. 
The product of the reaction was rigorously identified by 
physical methods. Large-scale standard incubations (total of 
300 mL) were performed with [ l 3 C H 3 ] S A M and a D E A E 
prepurified enzyme fraction. After 5 h of incubation at 37°C the 
mixture was passed through an X A D column that adsorbed the 
alkaloids. The column was washed thoroughly with distilled 
water and subsequently eluted with methanol. The eluate was 
evaporated and subjected to NMR analysis. Figure 3 shows a 
section of the NMR spectrum depicting clearly the 
l 3 C-enriched carbon atom, which is attached to C-13 of thalic­
tricavine (Fig. 3#). An aliquot of the enzymic reaction product 
was subjected to mass spectrometry (El-mode) and yielded a 
mass peak at 354 m/z (Fig. 4B\ one mass unit more than the 
unlabelled reference (Fig. 4A), as expected. Furthermore, a 
prominent benzylic fragment of rn/z 179 was observed, which 
represents the D ring of corydaline with the , 3 C H 3 group 
originating from S A M attached to it (Fig. 4B). No doubt, the 
reaction product is thalictricavine. To ascertain the correct 
stereochemistry of the thalictricavine formed, a C D spectrum of 
the enzyme-synthesized product was recorded. The C D spec­
trum of this compound shown in Fig. 5 is identical with that one 
published previously (14). The enzyme-synthesized product is 
therefore (+)-thalictricavine, identical with that compound pre­
viously isolated from various Corydalis species (5, 10-13, 15, 
16). 
Finally, the substrate specificity of this enzyme was of con­
siderable interest. Employing the reductive enzyme assay in the 
presence of [ C 3 H 3 ] S A M , N A D P H , and various alkaloidal sub­
strates using a 50-fold purified enzyme, the results shown in 
Table 3 were obtained. All protoberberines tested so far. except 
dehydroscoulerine, served as methyl group acceptor to varying 
degrees. Fully substituted protoberberines possessing no free 
O H group (berberine, palmatine) were the best substrates, fol­
lowed by alkaloids having one unsubstituted O H group (colum-
bamine, jatrorrhizine). The tetrahydroprotoberberines were 
completely inactive. Dehydroscoulerine was absolutely inac­
tive in this system. This is in accord with the previously found 
reductase (7), which also is almost inactive with this substrate. 
It is most likely that this reductase, which operates in two steps 
(7), first reducing the 7,8 double bond and subsequently the 
13,14 double bond, to yield the (/?)-tetrahydroprotoberberines, 
is identical with that needed for (+)-thalictricavine biosynthe­
sis. The assumption that this very enzyme is involved in thalic­
tricavine biosynthesis is supported by the fact that 7,8-di-
hydroberberine serves indeed as an excellent substrate for the 
methyltransferase with concomitant reduction to the (/^-con­
figurated (+)-thalictricavine (Table 3). Presuming that the pre­
viously found reductase (7) is involved in (+)-thalictricavine 
formation, the hydrogen transfer from N A D P 3 H should also 
follow a Β-type reaction. Incubation of berberine in the pres­
ence of S A M and either 4 A - 3 H - N A D P H or 4B- 3 H-NADPH 
(18) under optimal conditions, and isolation of the (+)- thalic­
tricavine formed, clearly showed that absolutely no tritium was 
transferred from 4 A - 3 H - N A D P H , while 48.8% of the radioac­
tivity of the 4 B - 3 H - N A D P H was found in thalictricavine. This 
clearly demonstrated that the reductase involved is a B-type 
enzyme and most likely identical with the (/?)-specific reduc­
tase found previously in C. cava (7). The (/?)- or (S)-tetrahydro-
protoberberines do not serve as acceptors for the methyl group 
of S A M . 
The biosynthesis of (-t-)-corydaline and congeners has now 
been worked out at the enzyme level. The protoberberine mol­
ecule is enzymically reduced by a specific dehydrogenase (7) to 
a 7,8-dihydro derivative. This intermediate (which can also be 
supplied in a synthetic form) acts at C-13 as an acceptor for the 
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T A B L E 2. Purification of S-adenosylmethionine: protoberberine-13C-methyltransferase from 40 g 
Corydalis cava cultivated cells 
Total Specific Purification 
Purification activity Total protein activity Yield factor 
step (pkat) (mg) (pkat/mg) (%) (x) 
Crude extract 261 440.0 0.6 100 1.0 
XAD-2 240 242.0 1.0 92 1.7 
DEAE-Sephacel 153 43.3 3.5 58 5.8 
Hydroxyapatite 118 16.0 7.4 45 12.3 
SAH-AH Sepharose 4B 84 2.6 32.3 32 53.8 
7 -
6 -
& 5 -
> 
4 -
E 
C-5 
Reference C-13 
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C-5 
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FIG. 2. A: pH profile of the catalytic activity of the 50-fold enriched 
enzyme system yielding thalictricavine using standard incubation mix­
tures with 100 μΜ each of ( · — · ) Tris-HCl buffer; (O—O) K P 0 4 2 " 
buffer, at 37°C. B: Temperature profile using the standard incubation 
assay at pH 8.0. 
• - —•—_ „,„ _ „Λ.^.κ,·^ *>..,. 
Ί 1—1 1 1—1 1 '—I ' 1 '— I— '— I 1—I '—I 
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FIG. 3. Partial proton-decoupled 1 3 C NMR spectra of thalictricav­
ine. A: unlabelled reference compound; B: enzyme product formed by 
transfer of the methyl group from [ 1 3 C H 3 ] S A M . 
SAM-derived methyl group, and is subsequently reduced in a 
B-type reaction at the expense of N A D P H to yield the 
(14/?,135>(+)-corydaline-type molecule. The course of reac­
tion is depicted in Scheme 1. It is most rewarding to see that the 
prediction of MacLean and Spenser and co-workers (5, 15) 
based entirely on in vivo feeding experiments and theoretical 
considerations could be verified by the results given here, 
which were obtained in vitro. 
Experimental 
Plant material 
Plants of Corydalis cava were grown in pots in the greenhouse of 
this institute. Plant cell cultures of Corydalis cava were cultivated in 
1-L Erlenmeyer flasks containing 250 mL Linsmaier and Skoog 
medium (19) over a period of 7 days at 23°C on a gyratory shaker 
(100 rpm) at 750 lux. The cells were then harvested by suction filtra­
tion, frozen in liquid nitrogen, and stored at - 2 0 ° C . 
Reference alkaloids 
Thalictricavine, corydaline, and tetrahydrocorysamine were a kind 
gift of Prof. Slavik (Brno). Berberine and scoulerine were purchased 
from Roth (Karlsruhe). Coptisine and palmatine were donated by Dr. 
T. Tanahashi (Kobe). 7,8-Dihydroberberine was synthesized according 
to ref. 20. 
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FIG. 4. Partial mass spectra (chemical ionization; isobutane) of thal­
ictricavine. A: unlabelled reference compound; B: enzymic product 
formed by transfer of the methyl group from [ , 3 C H 3 ] S A M . 
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FIG. 5. CD spectrum of enzymically formed thalictricavine (con­
centration: 0.92 mg/2 mL methanol). Note positive value at 236 nm 
and 206 nm, negative at 192 nm analogous to (+)-corydaline (14). 
T A B L E 3. Substrate specificity of S-adenosylmethionine: 
protoberberine-13C-methyltransferase 
Substrate" 
Product formed 
(pmol) 
Relative activity 
(%) 
Berberine 900 100 
Dihydroberberine 837 93 
(/?,S)-Canadine 0 0 
Columbamine 243 27 
Coptisine 189 21 
Dehydroscoulerine 0 0 
Jatrorrhizine 603 67 
Palmatine 837 93 
aThe respective substrate (10 nmol) and 1 pkat of the enzyme were 
added to the standard assay and incubated for 15 min at 30°C. 
Labelled chemicals 
[C 3H 3]Methionine (3.15 χ 10 9Βς/μπιο1) was purchased from 
Amersham (U.K.) and transformed to S-adenosyl-(L)-methionine 
(SAM) by SAM-synthetase, isolated from Escherichia coli EWH 47 
according to ref. 21. [ 1 3 CH 3 )SAM was synthesized by the same proce­
dure using [ , 3CH3]methionine. Stereospecifically labelled 4A- and 
4B- 3NADPH were synthesized according to the method of Moran et 
al. (18). [8-3H)-Labelled coptisine, palmatine, and berberine were syn­
thesized by simultaneous reduction of all three protoberberines with 
NaB 3 H 4 and reoxidation of the corresponding (5>tetrahydroproto-
berberines was performed with (S)-tetrahydroprotoberberine oxidase 
(22). (S)-[8- !4C]Scoulerine was synthesized enzymatically in a 
two-step reaction by incubating (S)-norreticuline and [ l 4 C H 3 ] S A M , 
first with 5-adenosylmethionine:coclaurine-A/-methyltransferase (23) 
and then with the berberine bridge enzyme (24). (5)-[ 14-3H|Scoulerine 
was produced by incubation of (/?,S)-[l-3H]reticuline wiih the ber­
berine bridge enzyme (24). 
A ppl i cat ion expe ή me η ts 
Young bulbs of Corydalis cava were cut into srnadl pieces of 0.5 g 
fresh weight and incubated in 1 mL Knop's nutrient solution with ber­
berine, coptisine, or palmatine (each 7.83 χ ΙΟ 4 Βς/μιτιοί). After 
extraction with methanol the labelled alkaloids were purified on TLC 
plates in three solvent systems: (1) ethyl acetate:2-butanone:forrnic 
acid:H 20 (50:30:10:10), R{ thalictricavine = 0.89, Rf corydaline = 
0.86, /?f tetrahydrocorysamine = 0.94; (2) cyclohexane:diethylamine 
(9:1), Rf thalictricavine = 0.63, Rf corydaline = 0.55, Rf tetra­
hydrocorysamine = 0.71; (3) dioxane:cyclohexane:dicthylamine 
(10:20:0.5), Rf thalictricavine 0.84, R{ corydaline = 0.75, R{ tetrahy­
drocorysamine = 0.77. 
Enzyme assay 
Berberine (10 nmol), 1 nmol [C 3 H 3 ]SAM (20 000cpm), and 
100 nmol NADPH were incubated with 20 μιηοΐ K P 0 4 2 _ buffer (pH 
8.0) and 0.1-1 mg protein in a total volume of 250 μι for 30 min at 
37°C (standard incubation mixture). The reaction was stopped by the 
addition of 200 μ ί sodium carbonate buffer (pH 9.5) and the reaction 
product extracted with 400 μι isoamyl alcohol for 10 min in a rotary 
shaker. After centrifugation (3 min in an Eppendorf centrifuge) the 
radioactivity of a 2 0 0 - μ ί aliquot was determined in a scintillation 
counter. 
Enzyme purification 
Corydalis cava deep-frozen cultivated cells (40 g) were ground 
with a chilled mortar and pestle in 80 mL 10 mM KP0 4 2 ~ buffer (pH 
6.5, 10 mM ß-mercaptoethanol) for 15 min, filtered through four lay-
ers of cheesecloth, and centrifuged for 10 min at 20 000 x g. The 
supernatant was passed through an XAD-2 column (Serva, Heidelberg, 
2.5 cm χ 20 cm) to remove the alkaloids and pumped onto a DEAE 
column (DEAE-Sephacel, Pharmacia, 2.5 cm χ 25 cm, equilibrated 
with the extraction buffer) at a flow rate of 1 mL/min. Elution was per-
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H X H 3 
HA 
<Lc0NH 2 ^ Λ ^ 0 Ο Ν Η 2 
O C H 
O C H , 
S A M + S A H 
0 C H 3 
O C H , 
R 1 • R 2 S - C H 2 - * Berberine 
R 1 = R 2 = - C H 3 «Palmatine 
7.8-Dihydroderivative 
SCHEME 1 
R 1 + R 2 = - C H 2 - «Thalictricavine 
R 1 = R 2 = C H 3 -Corydaline 
formed with a gradient from O-l Μ KCl over 8 h in fractions of 
2.5 mL. The active fractions (98-115) were combined (57 mL) and 
pumped onto a hydroxyapatite column (Biorad, 1 cm χ 15 cm, equili­
brated with 10 mM KPO4 buffer, pH 6.5, 10 mM ß-mercaptoethanol) 
at a flow rate of 0.3 mL/min. The enzyme did not bind to the column 
but was eluted with the washthrough in 55 mL. This solution was 
slowly (0.2 mL/min) loaded onto an SAH-AH-Sepharose column 
(Pharmacia 1 cm χ 5 cm, equilibrated with 10 mM KP042"~ buffer, pH 
7.5, 10 mM ß-mercaptoethanol) and eluted with a linear gradient up to 
1 Μ KCl in 4 h. Fractions of 1.5 mL were collected. Enzyme activity 
was eluted with 1 Μ KCl in 7.5 mL. 
Product identification 
For identification of the product, four of the following large-scale 
assays were prepared: 10 mmol K P 0 4 2 buffer, pH 8.5, 1 μιηοΐ 
[ , 3 CH 3 )S AM, 10 μηιοί berberine, 50 μιηοΙ NADPH, 50 μιηοΐ NADP, 
50 μηιοί glucose-6-phosphate. 5 units glucose-6-phosphate-dehydro-
genase (Serva, Heidelberg), and 75 mL enzyme solution (DEAE- elu-
ate, 100 mg protein) in a total volume of 250 mL. After incubation (5 h 
at 37°C) the mixtures were passed through an XAD-2 column (2 cm χ 
10 cm) and the alkaloids eluted with methanol. After concentration 
under a stream of nitrogen, the product was purified by TLC (Mach-
erey & Nagel, Polygram SIL G/UV 254, solvent system cyclohex-
aneidiethylamine (9:1), Rf thalictricavine = 0.6, Rf SAM = 0.0), eluted 
with methanol, and subjected to mass spectrometry (MS 80 RFA, Kra-
tos, EI, 70 eV) and l 3 C NMR (in deuterated methanol-DMSO, A M , 
360, Bruker). The CD spectrum was measured in ethanol with a CD-6 
(Jobin-Yvon) instrument. 
Stereospecificity of Η-transfer from 4A- and 4B-3H-NADPH 
To test the stereospecificity of the reduction reaction 100 000 cpm 
4A- or 4B- 3 H-N ADPH (18) (1.63 x 108 Bq/μπιοΐ), 10 nmol berberine, 
and 1 nmol SAM were incubated with 0.2 pkat of the enzyme in 
50 μηιοί K P 0 4 2 " buffer, pH 8.0, at 30°C for 1 h. The reaction product 
was purified by TLC (cyclohexane:diethylamine (9:1), Rf thalictric­
avine = 0.6) and eluted with methanol. Scintillation counting of the 
methanol eluate showed no incorporation with 4A- 3 H-NADPH, but 
with 4B- 3H-NADPH 48775 cpm (48.8%) could be detected in 
thalictricavine. 
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